Lundbeck
HLUN-B.CO
#2596
Rank
ยฃ4.96 B
Marketcap
ยฃ5.24
Share price
0.63%
Change (1 day)
9.80%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): ยฃ0.64 Billion

According to Lundbeck's latest financial reports the company's current earnings are ยฃ3.61 Billion. In 2024 the company made an earning of ยฃ0.41 Billion, an increase over its 2023 earnings that were of ยฃ0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.64 B55.12%
2024 ยฃ0.41 B25.74%
2023 ยฃ0.33 B21.77%
2022 ยฃ0.27 B31.57%
2021 ยฃ0.20 B-4.61%
2020 ยฃ0.21 B-45.06%
2019 ยฃ0.39 B-34.04%
2018 ยฃ0.59 B12.83%
2017 ยฃ0.52 B93.99%
2016 ยฃ0.27 B-137.28%
2015 -ยฃ0.74 Billion-1246.24%
2014 ยฃ63.77 M-72.36%
2013 ยฃ0.23 B4.38%
2012 ยฃ0.22 B-55.18%
2011 ยฃ0.49 B5.65%
2010 ยฃ0.46 B-5.9%
2009 ยฃ0.49 B